SCHEDULE SHARES ISSUABLE UNDER WARRANTS OUTSTANDING (Details) - $ / shares |
9 Months Ended | 12 Months Ended |
|---|---|---|
Jun. 30, 2026 |
Sep. 30, 2025 |
|
| Equity [Abstract] | ||
| Warrant Shares Outstanding, Beginning Balance | 1,667,106 | |
| Weighted Average Exercise Price, Beginning Balance | $ 4.84 | |
| Weighted Average Remaining Contractual Term, Outstanding | 2 years 3 months | 3 years 4 months 13 days |
| Warrants granted | ||
| Warrants exercised | (2,504,453) | |
| Weighted Average Exercise Price, Warrants exercised | $ 2.31 | |
| Warrants forfeited | ||
| Warrants cancelled | ||
| Exercise price adjustments | 1,852,896 | |
| Warrant Shares Outstanding, Ending Balance | 1,015,549 | 1,667,106 |
| Weighted Average Exercise Price, Ending Balance | $ 2.26 | $ 4.84 |
| X | ||||||||||
- Definition Share based compensation arrangement by sharebased payment award non option equity instruments cancelled No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non option equity instruments exercise price adjustment. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by sharebased payment award non option equity instruments exercised weighted average exercise price No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non option equity instruments outstanding weighted average exercise price. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by sharebased payment award nonoption equity instruments outstanding weighted average remaining contractual term. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements that were cancelled as a result of occurrence of a terminating event. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|